
Bioorganic and Medicinal Chemistry Letters p. 505 - 510 (1998)
Update date:2022-08-03
Topics:
Segarra, Victor
Crespo, M. Isabel
Pujol, Ferran
Beleta, Jorge
Domenech, Teresa
Miralpeix, Montserrat
Palacios, Jose M.
Castro, Ana
Martinez, Ana
A 4-centre PDE 4 pharmacophore search has been carried out in several 3D-databases containing compounds belonging to different therapeutic areas. Losartan, an angiotensin-II antagonist, has been identified as a new lead compound for developing PDE 4 inhibitors. New families of compounds derived from losartan has been synthesized and their PDE inhibition has been measured.
View MoreJiangxi Province Bethel Pharmaceutical Co., Ltd.
Contact:+86-795-259 3456 ,+86-15957688008 13566650571
Address:Huangjindui Chemical Park, Shanggao County ,Yichun city,Jiangxi Province
Contact:+86-0512-88957371
Address:shanghai
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
Cangzhou Senary Chemical Science-tech Co., Ltd
Contact:+86-317-3563899, 3563699
Address:168 Jinde Road, Cangzhou, Hebei, China
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Doi:10.1007/s10593-007-0073-2
(2007)Doi:10.1039/c9md00064j
(2019)Doi:10.1021/ol800653d
(2008)Doi:10.1007/s10593-007-0044-7
(2007)Doi:10.1021/jo00366a041
(1986)Doi:10.1271/bbb.70236
(2007)